Current debates surrounding provision of health care and health care systems address such business issues as: bringing medical and technological innovation to the market, provision and financing of health care, the balance of responsibilities between government, employer and individual, and the growth of genomics. These issues, which are being discussed at the OECD, United Nations, WHO and International Labor Organization, are of direct interest to the health care industries and to all employers.
Provide intergovernmental organizations with timely and objective information, expertise and policy advice on the broader economic and social consequences of national health care policies; the long-term innovative potential of the health care sector and the broader health ecosystem; the quality and costs of health care labor and technology; and the health care related impacts on capacity of employers to compete and provide jobs and support their employees.
· Through BIAC engagement in the OECD, promote a regulatory environment conducive to a wide range of health-related innovation and its diffusion; and support development of robust comparative health sector data as basis for developing health policy options.
Senior Director, Global Institutions
Senior Director, Product Policy and Innovation
212-703-5047 or email@example.com
Policy and Program Associate
212-703-5082 or firstname.lastname@example.org
· Organized a multistakeholder luncheon during the UN Civil Society Hearings on Non-communicable Diseases (NCD’s) in June 2011 and prepared business input into the UN High Level Meeting on NCD’s in September 2011.
· Participated in BIAC meetings with OECD Health Committee and its Secretariat to provide input for the preparation of the 2010 OECD Health Ministerial.
· Met with US government officials and OECD staff to recommend that OECD governments take a horizontal approach to addressing health care challenges and that the OECD Health Committee’s work should support and reflect the OECD horizontal approach on innovation strategy.
· Organized meeting with OECD Health Secretariat to provide input for the OECD’s project on the economics of the prevention of lifestyle related chronic diseases which resulted in having US business comments reflected in most recent OECD report on “Summary of findings and policy implications concerning the prevention of chronic diseases linked to unhealthy diets and sedentary lifestyles”.
· Delivered international industry submission to OECD Experts Meeting on pharmaceutical pricing policy.